Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis
- PMID: 33142704
- PMCID: PMC7694072
- DOI: 10.3390/biomedicines8110464
Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis
Abstract
This review aims to be an update of Bioengineered Artificial Skin Substitutes (BASS) applications. At the first moment, they were created as an attempt to replace native skin grafts transplantation. Nowadays, these in vitro models have been increasing and widening their application areas, becoming important tools for research. This study is focus on the ability to design in vitro BASS which have been demonstrated to be appropriate to develop new products in the cosmetic and pharmacology industry. Allowing to go deeper into the skin disease research, and to analyze the effects provoked by environmental stressful agents. The importance of BASS to replace animal experimentation is also highlighted. Furthermore, the BASS validation parameters approved by the OECD (Organisation for Economic Co-operation and Development) are also analyzed. This report presents an overview of the skin models applicable to skin research along with their design methods. Finally, the potential and limitations of the currently available BASS to supply the demands for disease modeling and pharmaceutical screening are discussed.
Keywords: animal experimentation; atopic dermatitis; bioengineered artificial skin substitutes; fibroblasts; keratinocytes; product testing; psoriasis; regenerative medicine; tissue engineering; transepidermal water loss.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Bioengineered Skin Intended for Skin Disease Modeling.Int J Mol Sci. 2019 Mar 20;20(6):1407. doi: 10.3390/ijms20061407. Int J Mol Sci. 2019. PMID: 30897791 Free PMC article. Review.
-
Cytotoxicity, Epidermal Barrier Function and Cytokine Evaluation after Antiseptic Treatment in Bioengineered Autologous Skin Substitute.Biomedicines. 2022 Jun 19;10(6):1453. doi: 10.3390/biomedicines10061453. Biomedicines. 2022. PMID: 35740473 Free PMC article.
-
Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model.J Clin Med. 2021 Feb 8;10(4):642. doi: 10.3390/jcm10040642. J Clin Med. 2021. PMID: 33567522 Free PMC article.
-
From Grafts to Human Bioengineered Vascularized Skin Substitutes.Int J Mol Sci. 2020 Nov 2;21(21):8197. doi: 10.3390/ijms21218197. Int J Mol Sci. 2020. PMID: 33147759 Free PMC article. Review.
-
A new model for preclinical testing of dermal substitutes for human skin reconstruction.Pediatr Surg Int. 2013 May;29(5):479-88. doi: 10.1007/s00383-013-3267-y. Epub 2013 Feb 1. Pediatr Surg Int. 2013. PMID: 23371301
Cited by
-
Exosomes Derived From Umbilical Cord Mesenchymal Stem Cells Treat Cutaneous Nerve Damage and Promote Wound Healing.Front Cell Neurosci. 2022 Jun 30;16:913009. doi: 10.3389/fncel.2022.913009. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35846563 Free PMC article.
-
Urine-Derived Stem Cells for Epithelial Tissues Reconstruction and Wound Healing.Pharmaceutics. 2022 Aug 11;14(8):1669. doi: 10.3390/pharmaceutics14081669. Pharmaceutics. 2022. PMID: 36015295 Free PMC article. Review.
-
Boesenbergia rotunda and Its Pinostrobin for Atopic Dermatitis: Dual 5-Lipoxygenase and Cyclooxygenase-2 Inhibitor and Its Mechanistic Study through Steady-State Kinetics and Molecular Modeling.Antioxidants (Basel). 2024 Jan 5;13(1):74. doi: 10.3390/antiox13010074. Antioxidants (Basel). 2024. PMID: 38247498 Free PMC article.
-
Exosomes in Dermatology: Emerging Roles in Skin Health and Disease.Pharmaceutics. 2025 May 2;17(5):600. doi: 10.3390/pharmaceutics17050600. Pharmaceutics. 2025. PMID: 40430891 Free PMC article. Review.
-
Antibiotics against Pseudomonas aeruginosa on Human Skin Cell Lines: Determination of the Highest Non-Cytotoxic Concentrations with Antibiofilm Capacity for Wound Healing Strategies.Pharmaceutics. 2024 Jan 17;16(1):117. doi: 10.3390/pharmaceutics16010117. Pharmaceutics. 2024. PMID: 38258128 Free PMC article.
References
-
- Chandra P.K., Soker S., Atala A. Tissue engineering: Current status and future perspectives. In: Lanza R., Langer R., Vacanti J., Atala A., editors. Principles of Tissue Engineering. Volume 7. Academic Press; Winston-Salem, NC, USA: 2020. p. 1800457.
-
- Fernández-González A., Lizana-Moreno A., Ruiz-Garcia A., Guerrero-Calvo J., Espinosa O., Fernández N., Ordonez-Luque A., Sierra-Sanchez A., Arias-Santiago S. Optimization of an autologous human skin model under GMP guidelines. Cytotherapy. 2017;19:S232–S233. doi: 10.1016/j.jcyt.2017.02.338. - DOI
-
- Carriel V., Garzón I., Jiménez J.M., Oliveira A.C.X., Arias-Santiago S., Campos A., Sánchez-Quevedo M.C., Alaminos M. Epithelial and stromal developmental patterns in a novel substitute of the human skin generated with fibrin-agarose biomaterials. Cells Tissues Organs. 2012;196:1–12. doi: 10.1159/000330682. - DOI - PubMed